Grover P. Miller

University of Arkansas for Medical Sciences

Pharmacology, Toxicology and PharmaceuticsComputer ScienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam”.

Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam

Toxicology Letters(2020)10.1016/j.toxlet.2020.11.015

N/A

0.483DataRank · unranked

24 citations

Mary A. Schleiff, Arghya Datta, Noah R. Flynn, S. Joshua Swamidass, Grover P. Miller +1 more

Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics

Drug Metabolism and Disposition(2020)10.1124/dmd.120.000254

N/A

0DataRank · unranked

12 citations

Noah R. Flynn, Sasin Payakachat, Benjamin Mark Schleiff, Anna O. Pinson, Dennis W. Province +4 more

Novel advances in biotransformation and bioactivation research—2019 year in review

Drug Metabolism Reviews(2020)10.1080/03602532.2020.1772281

N/A

0DataRank · unranked

6 citations

James P. Driscoll, Klarissa D. Jackson, Grover P. Miller, Kaushik Mitra, Ivonne M.C.M. Rietjens +2 more

4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00933

N/A

0DataRank · unranked

36 citations

Angela S. Carlson, Mary A. Schleiff, Anand Divakaran, Jorden A. Johnson, Caroline R. Buchholz +9 more

Impacts of diphenylamine NSAID halogenation on bioactivation risks

Toxicology(2021)10.1016/j.tox.2021.152832

N/A

0DataRank · unranked

8 citations

Sasin Payakachat, Benjamin Mark Schleiff, S. Joshua Swamidass, Gunnar Boysen, Grover P. Miller +1 more

CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114824

N/A

0DataRank · unranked

7 citations

Samantha Crosby, Madison Blue, Benjamin Mark Schleiff, Gunnar Boysen, Grover P. Miller +1 more

Bioactivation and reactivity research advances – 2021 year in review

Drug Metabolism Reviews(2022)10.1080/03602532.2022.2097254

N/A

0DataRank · unranked

3 citations

Upendra A. Argikar, Sungjoon Cho, Rachel D. Crouch, James P. Driscoll, Carley J. S. Heck +9 more

Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin

Frontiers in Pharmacology(2022)10.3389/fphar.2021.805133

N/A

0DataRank · unranked

1 citations

Dustyn A. Barnette, Riley W. Sinnott, Sarah Phillips, Noah R. Flynn, Howard P. Hendrickson +3 more

The Role of Cytochrome P450 3A4-Mediated Metabolism in Sorafenib and Lapatinib Hepatotoxicity

Livers(2023)10.3390/livers3020022

N/A

0DataRank · unranked

12 citations

Yihong Kaufmann, Francesca V. LoBianco, Mary A. Schleiff, Nükhet Aykin‐Burns, Grover P. Miller +1 more

Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam

Toxicology(2020)10.1016/j.tox.2020.152478

N/A

0DataRank · unranked

19 citations

Mary A. Schleiff, Laura Osborn, Noah R. Flynn, Matthew K. Matlock, S. Joshua Swamidass +2 more

The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications

Neuroscience & Biobehavioral Reviews(2025)10.1016/j.neubiorev.2025.106043

N/A

0DataRank · unranked

8 citations

Ali S. Taha, Grover P. Miller, Austin T. Jones